MCRB icon

Seres Therapeutics

137 hedge funds and large institutions have $538M invested in Seres Therapeutics in 2023 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 59 increasing their positions, 23 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
137
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$12.8M
Puts
$4.23M
Net Calls
Net Calls Change

Top Buyers

1 +$23M
2 +$9.8M
3 +$6.47M
4
BlackRock
BlackRock
New York
+$5.9M
5
ACA
Avoro Capital Advisors
New York
+$5.77M

Top Sellers

1 -$25M
2 -$18.6M
3 -$4.36M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$2.38M
5
Citadel Advisors
Citadel Advisors
Florida
-$2.34M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$209K
77
$205K
78
$200K
79
$199K
80
$197K
81
$191K
82
$186K
83
$186K
84
$185K
85
$172K
86
$162K
87
$150K
88
$147K
89
$139K
90
$136K
91
$131K
92
$119K
93
$108K
94
$101K
95
$100K
96
$94.4K
97
$93.4K
98
$87.7K
99
$86.2K
100
$85.1K